Fentanes, Emilio
Cainzos Achirica, Miguel
Nasir, Khurram
Blankstein, Ron
Article History
Accepted: 23 July 2021
First Online: 15 September 2021
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Khurram Nasir is on the Advisory Boards of Amgen, Novartis, and Novo Nordisk. His research is partly supported by the Jerold B. Katz Academy of Translational Research.Dr. Blankstein has received research support from Amgen Inc. and Novartis Inc; and is on the Advisory boards of Caristo and Roivant Sciences Inc, outside the submitted work.The other authors report no conflicts of interest.